Inventor · disambiguated record
Paul F. Torrence
Also filed as: TORRENCE PAUL · TORRENCE PAUL F
7 granted patents·1 pending application·458 citations·filing 1983–2003
90Inventor score
Files withCLEVELAND CLINIC FOUNDATION3US HEALTH3CLEVELAND CLINIC FOUINDATION A1CLEVELAND CLINIC FOUNDATION AN1
Top patents by PatentIndex Score
8 records- 0193US6214805B1RNase L activators and antisense oligonucleotides effective to treat RSV infectionsUS HEALTH·Filed 1997·Granted Apr 10, 2001·174 cites·15 claims
- 0287US4515781A2',5'-Riboadenylate-morpholinoadenylate nucleotidesUS HEALTH·Filed 1983·Granted May 7, 1985·56 cites·10 claims
- 0386US5998602ARNase L activators and antisense oligonucleotides effective to treat RSV infectionsCLEVELAND CLINIC FOUINDATION A·Filed 1997·Granted Dec 7, 1999·103 cites·7 claims
- 0481US5583032AMethod of cleaving specific strands of RNACLEVELAND CLINIC FOUNDATION AN·Filed 1993·Granted Dec 10, 1996·56 cites·21 claims
- 0575US5677289AMethod of cleaving specific strands of RNA and medical treatments therebyCLEVELAND CLINIC FOUNDATION·Filed 1995·Granted Oct 14, 1997·22 cites·11 claims
- 0672US6468983B2RNase L activators and antisense oligonucleotides effective to treat telomerase-expressing malignanciesCLEVELAND CLINIC FOUNDATION·Filed 1998·Granted Oct 22, 2002·32 cites·29 claims
- 0764US6271369B1Chimeric molecules targeted to viral RNAsUS HEALTH·Filed 1997·Granted Aug 7, 2001·15 cites·9 claims
- 0842US2003203356A1RNase L activator-antisense complexesCLEVELAND CLINIC FOUNDATION·Filed 2003·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →